Trials / Completed
CompletedNCT02262949
A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System
A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System (REALITY2)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the deliverability, clinical utility, safety and effectiveness of the 250 mm length size offering of the LifeStent® Vascular Stent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LifeStent Vascular Stent | PTA followed by implantation of the LifeStent Vascular Stent (stent length 250 mm) in the SFA or popliteal artery. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-07-01
- Completion
- 2016-07-01
- First posted
- 2014-10-13
- Last updated
- 2016-12-07
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02262949. Inclusion in this directory is not an endorsement.